INTRODUCTION
============

*Helicobacter pylori* (*H. pylori*) infection is related to the development of gastritis, peptic ulcer, and gastric adenocarcinoma.[@B1] A hallmark of *H. pylori*-associated gastric change is hyperproliferation of gastric epithelial cells.[@B2][@B3] Oncogenes, such as β-catenin and c-myc, stimulate cell proliferation and promote malignant changes. *H. pylori* infection leads to an increase of nuclear β-catenin in gastric epithelial NCI-N87 cells.[@B4] In the nucleus, β-catenin serves as a transcriptional regulator.[@B5][@B6] c-Myc is one of target genes that are regulated by β-catenin.[@B7] As a proto-oncogene, c-myc stimulates the expression of genes, which are involved in cell proliferation.[@B8]

Reactive oxygen species (ROS) are one of the potential toxic factors in *H. pylori*-induced gastric injury.[@B9] The levels of ROS were increased in the gastric mucosa of *H. pylori*-infected patients.[@B10] Previously, we and others showed that nicotinamide adenine dinucleotide phosphate oxidase produces ROS in *H. pylori*-infected gastric epithelial cells[@B11] and gastric mucosa of humans and mice.[@B12][@B13] *H. pylori*-induced ROS production stimulates the expression of various genes by activating NF-κB and AP-1.[@B14] Since these redox-sensitive transcription factors are activated by ROS,[@B15] ROS may trigger the activation of these transcription factors in *H. pylori*-infected gastric epithelial cells. NF-κB regulates immune response, inflammatory reactions, cell proliferation, and apoptosis. IκB-α acts as the cytoplasmic inhibitory protein of NF-κB.[@B16] Activation of NF-κB and AP-1 is shown in *H. pylori*-infected human gastric epithelial AGS cells.[@B17] Nollet, et al.[@B18] reported that NF-κB and AP-1 play a role in β-catenin expression in certain situations. However, whether NF-κB and AP-1 directly regulate the expression of β-catenin or c-myc in *H. pylori*-infected cells has not been clarified. The purpose of this study is to investigate whether *H. pylori*-induced activation of NF-κB and AP-1 mediates the expression of oncogenes (β-catenin, c-myc) and hyperproliferation of gastric epithelial cells.

MATERIALS AND METHODS
=====================

A human gastric epithelial cell line AGS (adenocarcinoma gastric, ATCC CRL 1739) and *H. pylori* (strain NCTC 11637) were obtained from the American Type Culture Collection (Manassas, VA, USA). AGS cells were cultured as previously described.[@B14] *H. pylori* was inoculated onto chocolate agar plates at 37℃ under microaerophilic conditions using GasPak™ EZ Gas Generating Pouch Systems (BD Biosciences, San Jose, CA, USA).[@B14] Prior to infection, *H. pylori* were harvested and then suspended in antibiotic-free cell culture medium. *H. pylori* was added to cultured cells at a bacterium/cell ratio 50:1. In the ratio of bacterium/cell (50:1), *H. pylori* did not induce apoptotic cell death, which was reported in our previous study.[@B19]

A mutated IκBα gene, called *MAD3* double-point mutant was prepared as described previously[@B14] to inhibit activation of NF-κB. A dominant negative mutant of c-Jun, called *TAM67*, was a kind gift from Dr. Andreas von Knethen (University of Erlangen, Erlangen, Germany) and transfected to AGS cells to inhibit AP-1 activation. The control vector pcDNA (Invitrogen Corp., Carlsbad, CA, USA) was transfected to the cells instead of mutant genes for IκBα (*MAD3*) and c-Jun (*TAM67*). Subconfluent AGS cells were transfected with DOTAP {N-\[1-(2,3-dioleoyloxy) propyl\]-N,N,N trimethyl ammonium methylsulfate} (Boehringer-Mannheim, Pentzberg, Germany) for 16 h.[@B11] The transfected cells were cultured with or without *H. pylori*.[@B11] Wild-type cells were cultured with or without *H. pylori* and expressed as control and none cells. The cells transfected with pcDNA, *MAD3*, and *TAM67* were expressed as pcDNA, *MAD3*, and *TAM67* cells. In the other set of experiment, AGS cells were treated with a specific NF-κB inhibitors caffeic acid phenethyl ester (CAPE) (40 µM) (Sigma-Aldrich, St. Louis, MO, USA) or selective AP-1 inhibitor SR-11302 (2 µM) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 2 h before *H. pylori* infection and cultured for 24 h (protein levels of oncogenes) and 48 h (viable cell numbers).

The cells were infected with *H. pylori* for 1 h (for NF-κB and AP-1), 24 h (for thymidine incorporation and oncogene expression), and for 72 h (viable cell numbers). The time points for determining NF-κB and AP-1, thymidine incorporation, oncogene expression, and viable cell numbers were adapted from a previous study.[@B11]

Viable cell numbers was determined by direct counting with a hemocytometer using the trypan blue exclusion test. For thymidine incorporation, 1 µCi/mL \[^3^H\] thymidine (Amersham Biosciences, Piscataway, NJ, USA) was added to the cells and cultured with or without *H. pylori* for 24 h.[@B20] The cells were washed, incubated in 10% trichloroacetic acid and a solution consisting of 0.3 M NaOH and 1% sodium dodecyl sulfate (SDS) as described.[@B20] The radioactivity of cell extracts was measured by liquid scintillation counting. The relative amount of \[^3^H\] thymidine incorporation, which reflected the extent of DNA synthesis, was expressed as a percentage of wild-type cells cultured without *H. pylori* (none).

Nuclear extracts were prepared for electrophoretic mobility shift assay.[@B14] DNA binding activity of NF-κB or AP-1 was determined by the previously described method.[@B14]

For real-time PCR analysis, total RNA in cells were isolated and converted into cDNA by reverse transcription process using a random hexamer and virus reverse transcriptase (Promega, Madison, WI, USA). RNA expression levels of β-catenin, c-myc and β-actin were determined by the method described previously.[@B11]

For Western blot analysis, proteins in whole cell extracts were subjected to 8--12% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked using 3--5% nonfat dry milk in Tris-buffered saline and 0.2% Tween 20 (TBS-T), incubated with antibodies for β-catenin, c-myc, or actin (Santa Cruz Biotechnology, Dallas, TX, USA) diluted in TBS-T containing 3% dry milk, and washed with TBS-T. Primary antibodies were detected using horseradish peroxidase-conjugated secondary antibodies and visualized by the enhanced chemiluminescence detection system (Santa Cruz Biotechnology).[@B11] To measure the density ratios among protein bands, the blots were scanned using a Bio-Rad laser densitometer (GS-700). The Scion image program (Scion Corporation, Frederick, MD, USA) was used to measure band intensities. The Western blot results presented in each figure are representative of four independent experiments. The protein level was compared to that of the loading control actin and expressed as the percentage ratio of the band densities.

One-way ANOVA and Newman-keul\'s test were used for determining the statistical differences. All values are expressed as mean±SE of four different experiments. A value of *p*\<0.05 was considered statistically significant.

RESULTS
=======

To determine the role of NF-κB and AP-1 in cell proliferation and oncogene expression, the cells were transiently transfected with mutant genes for IκBα (*MAD3*) and c-Jun (*TAM67*) and then cultured with *H. pylori*. As shown [Fig. 1A](#F1){ref-type="fig"}, *H. pylori*-infection induced activation of NF-κB and AP-1 in wild-type cells (control) and the cells transfected with pcDNA (pcDNA) at 1 h-culture. *H. pylori*-induced activation of NF-κB and AP-1 were inhibited by transfection of *MAD3* and *TAM67*. Similarly, *H. pylori*-stimulated cell proliferation time-dependently ([Fig. 1B](#F1){ref-type="fig"}), and DNA synthesis at 24 h-culture ([Fig. 1C](#F1){ref-type="fig"}) was inhibited by transfection with the mutants. However, transfection of *MAD3* and *TAM67* had no effect on the cells cultured without *H. pylori*. It may be explained that NF-κB and AP-1 were not activated in the cells cultured without *H. pylori*. As shown in [Fig. 2](#F2){ref-type="fig"}, the mRNA and protein levels of β-catenin and c-myc were lower in the cells transfected with *MAD3* and *TAM67* than those transfected with pcDNA or wild-type cells cultured with *H. pylori* at 24 h-culture.

CAPE, one of the active compounds of propolis, has been shown to inhibit NF-κB activation.[@B21][@B22] SR-11302 is a retinoid that transrepresses AP-1 without transactivating the retinoic acid response element.[@B23][@B24] To investigate the involvement of NF-κB and AP-1 activities on *H. pylori*-induced oncogene expression and hyperproliferation, the cells were pretreated with CAPE or SR-11302 and then cultured with *H. pylori*. As shown in [Fig. 3](#F3){ref-type="fig"}, CAPE and SR-11302 inhibited *H. pylori*-induced cell proliferation (determined by viable cell numbers at 48 h-culture) in AGS cells ([Fig. 3A](#F3){ref-type="fig"}). *H. pylori*-induced expression of β-catenin and c-myc was inhibited by CAPE and SR-11302 in AGS cells at 24 h-culture ([Fig. 3B](#F3){ref-type="fig"}). Taken together, *H. pylori*-induced oncogene expression and hyperproliferation are mediated by activation of NF-κB and AP-1 in gastric epithelial AGS cells.

DISCUSSION
==========

In the present study, we found that activation of NF-κB and AP-1 transcriptionally regulate cell proliferation and expression of β-catenin and c-myc in *H. pylori*-infected gastric epithelial AGS cells. Hyper-proliferation of gastric epithelial cells and up-regulation of several gene expressions are reported to be associated with ROS under *H. pylori* infection. Even though ROS are considered to be responsible for the proliferation and oncogene expression, how ROS mediate cell proliferation in *H. pylori*-infected cells has not been clarified. We demonstrated that redox-sensitive transcription factors NF-κB and AP-1 mediate cell proliferation by inducing important oncogenes β-ca-tenin and c-myc in *H. pylori*-infected AGS cells. However, this study is limited in proving the hypothesis since AGS cells are already transformed cancer cells. Further study should be performed to establish the role of NF-κB and AP-1 on oncogene expression using primary gastric epithelial cells isolated from normal gastric tissues and *in vivo* animal models.

For the signaling mechanism for cell proliferation, β-catenin inactivates glycogen synthase kinase 3β and migrates to the nucleus, which induces the expression of cyclin D1. Bandapalli, et al.[@B25] reported that overexpression of β-catenin increases its nuclear level and carcinogenesis including metastasis. In the present study, inhibition of NF-κB and AP-1 upon transfection of *MAD3* or *TAM67* suppressed the expression of β-catenin in *H. pylori*-infected cells. These results suggest that *H. pylori* may activate β-catenin through modulation of NF-κB and AP-1 activities in gastric epithelial cells. Even though c-myc expression is reported to be regulated by β-catenin,[@B7][@B8] there has been no studies to determine the role of NF-κB and AP-1 on c-myc expression in gastric epithelial cells. In the present study, we found that NF-κB and AP-1 regulate the expression of both β-catenin and c-myc at the transcription level, which was determined using transfection of *MAD3* (a mutated IκBα gene) or *TAM67* (a dominant negative mutant of c-Jun) or treatment with CAPE (a specific NF-κB inhibitor) or SR-11302 (a selective AP-1 inhibitor). Therefore, targeting transcription factor NF-κB and AP-1 may be beneficial for preventing progression of *H. pylori*-associated carcinogenesis by suppressing expression of β-catenin and c-myc, as well as hyper-proliferation of gastric epithelial cells.
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![Activation of NF-κB and AP-1, viable cell numbers, and thymidine incorporation of *H. pylori*-infected cells with or without transfection of *MAD3* or *TAM67*. (A) The cells were cultured with *H. pylori* for 1 h. The DNA binding activities of NF-κB and AP-1 were determined by EMSA. (B) Viable cell numbers were determined by the trypan blue exclusion assay for indicated time period. ^\*^*p*\<0.05 vs. 0 h, ^†^*p*\<0.05 vs. *H. pylori* (the cells without transfection of *MAD3* and *TAM67* and cultured with *H. pylori*) or *H. pylori*+pcDNA (the cells with transfection of pcDNA and cultured with *H. pylori*). (C) DNA synthesis was determined by thymidine incorporation. \[^3^H\] Thymidine was added to the cells and cultured with *H. pylori* for 24 h. ^\*^*p*\<0.05 vs. corresponding none (the cells cultured without *H. pylori*), ^†^*p*\<0.05 vs. corresponding *H. pylori* (the cells without transfection of *MAD3* and *TAM67* and cultured with *H. pylori*) or *H. pylori* pcDNA (the cells with transfection of pcDNA and cultured with *H. pylori*). AGS, adenocarcinoma gastric; EMSA, lectrophoretic mobility shift assay; *H. pylori*, *Helicobacter pylori*.](ymj-57-647-g001){#F1}

![Expression of β-catenin and c-myc of *H. pylori*-infected AGS cells with or without transfection of *MAD3* or *TAM67*. The cells were cultured in with or without *H. pylori* for 24 h. (A) mRNA expression of β-catenin and c-myc were measured by real-time PCR analysis. ^\*^*p*\<0.05 vs. none (the cells cultured without *H. pylori*), ^†^*p*\<0.05 vs. *H. pylori* control (the cells without transfection of *MAD3* and *TAM67* and cultured in with *H. pylori*) or *H. pylori* pcDNA (the cells transfected with pcDNA and cultured with *H. pylori*). (B) Protein levels of β-catenin and c-myc were determined by Western blot analysis. Actin served as a loading control. The protein level was compared to that of the loading control actin and expressed as the percentage ratio of the band densities. All data are presented as the mean±SE of four independent experiments. ^\*^*p*\<0.05 vs. none (the cells cultured without *H. pylori*), ^†^*p*\<0.05 vs. *H. pylori* control (the cells without transfection of *MAD3* and *TAM67* and cultured in with *H. pylori*) or *H. pylori* pcDNA (the cells transfected with pcDNA and cultured with *H. pylori*). *H. pylori*, *Helicobacter pylori*.](ymj-57-647-g002){#F2}

![Viable cell numbers and expression of β-catenin and c-myc of *H. pylori*-infected AGS cells with treatment of CAPE or SR-11302. (A) The cells were pretreated with CAPE or SR-11302 and cultured with *H. pylori* for 48 h. Viable cell numbers were determined by the trypan blue exclusion assay. ^\*^*p*\<0.05 vs. none, ^†^*p*\<0.05 vs. *H. pylori* control (the cells without treatment of CAPE or SR-11302 and cultured with *H. pylori*). (B) Protein levels of β-catenin and c-myc were determined by Western blot analysis. Actin served as a loading control. The protein level was compared to that of the loading control actin and expressed as the percentage ratio of the band densities. All data are presented as the mean±SE of four independent experiments. ^\*^*p*\<0.05 vs. none (the cells cultured without *H. pylori*), ^†^*p*\<0.05 vs. *H. pylori* control (the cells with *H. pylori*). *H. pylori*, *Helicobacter pylori*.](ymj-57-647-g003){#F3}
